Dr. Teja Poosarla, MD

Claim this profile

University of South Alabama Mitchell Cancer Institute

Studies Breast Cancer
Studies Cancer
5 reported clinical trials
15 drugs studied

Area of expertise

1Breast Cancer
Teja Poosarla, MD has run 5 trials for Breast Cancer. Some of their research focus areas include:
Stage III
Stage IV
HER2 negative
2Cancer
Teja Poosarla, MD has run 1 trial for Cancer.

Affiliated Hospitals

Image of trial facility.
University Of South Alabama Mitchell Cancer Institute
Image of trial facility.
Inova Schar Cancer Institute

Clinical Trials Teja Poosarla, MD is currently running

Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria

More about Teja Poosarla, MD

Clinical Trial Related8 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Teja Poosarla, MD has experience with
  • Pelareorep
  • Avelumab
  • Paclitaxel
  • Tucatinib
  • T-DM1
  • Placebo
Breakdown of trials Teja Poosarla, MD has run
Breast Cancer
Cancer

Other Doctors you might be interested in

Matthew Sherwood, MDInova Fairfax Hospital
David P. Lee, MDStanford Hospital and Clinics
Adam Cohen, MDInova Schar Cancer Institute

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Teja Poosarla, MD specialize in?
Teja Poosarla, MD focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved Stage III patients, or patients who are Stage IV.
Is Teja Poosarla, MD currently recruiting for clinical trials?
Yes, Teja Poosarla, MD is currently recruiting for 1 clinical trial in Mobile Alabama. If you're interested in participating, you should apply.
Are there any treatments that Teja Poosarla, MD has studied deeply?
Yes, Teja Poosarla, MD has studied treatments such as Pelareorep, Avelumab, Paclitaxel.
What is the best way to schedule an appointment with Teja Poosarla, MD?
Apply for one of the trials that Teja Poosarla, MD is conducting.
What is the office address of Teja Poosarla, MD?
The office of Teja Poosarla, MD is located at: University of South Alabama Mitchell Cancer Institute, Mobile, Alabama 36604 United States. This is the address for their practice at the University of South Alabama Mitchell Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top